A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: initial (387), budding (11), early (483)

Prof Robert Read, director NIHR Southampton Biomedical Research Centre

Description
NIHR Southampton Biomedical Research Centre Auto Generated Title Professor Read is director of the NIHR Southampton Biomedical Research Centre a
Url
/ClinicalResearchinSouthampton/Our-people/Directors/Prof-Robert-Read-director-NIHR-Southampton-Biomedical-Research-Centre.aspx

Ready Steady Go - Parent plan (print ready)

Description
Parent/carer's transition programme Name of parent: Name of patient: Date: Review (1) Review (2) Review (3) Internet access: YES/NO
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/ReadySteadyGo/Printready/Ready-Steady-Go-parent-plan-print-ready.pdf

B-AVD (Brentuximab vedotin-Dacarbazine-Doxorubicin-Vinblastine)

Description
Chemotherapy Protocol LYMPHOMA BRENTUXIMAB VEDOTIN-DACARBAZINE-DOXORUBICIN-VINBLASTINE (B- AVD) Regimen • Lymphoma – Brentuximab vedotin - Dacarbazine-Doxorubicin-Vinblastine Indication • Previously untreated stage
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/B-AVD-Brentuximab-vedotin-Dacarbazine-Doxorubicin-Vinblastine.pdf

Squint in children - patient information

Description
This factsheet contains information about squint in children.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Squint-in-children-1776-PIL.pdf

Mycophenolate to treat myasthenia - patient information

Description
This factsheet contains information about the use of mycophenolate to treat myasthenia, including how the treatment is given and the possible
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Mycophenolate-to-treat-myasthenia-3041-PIL.pdf

Urodynamics test at the urology centre - patient information

Description
This factsheet explains what a urodynamics test is and what will happen at your appointment.
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Urodynamics-test-at-the-urology-centre-1487-PIL.pdf

Your child's vision screening clinic referral - patient information

Description
This factsheet explains what the vision screening clinic is and what will happen at your child's appointment.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Your-childs-vision-screening-clinic-referral-3778-PIL.pdf

Workforce Race Equality Standard annual report 2024

Description
Executive Summary WRES Data has been submitted by the Trust since 2015 and progress is reviewed against the nine indicators contained
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Equality-reports/UHS-WRES-report-2024.pdf

EC-PPH Cyclophosphamide Epirubicin Paclitaxel Pertuzumab Trastuzumab

Description
Chemotherapy Protocol BREAST CANCER CYCLOPHOSPHAMIDE-EPIRUBICIN-PACLITAXEL-PERTUZUMABTRASTUZUMAB (EC-PPH) Regimen • Breast Cancer – Cyclophosphamide-Epirubicin-Paclitaxel-PertuzumabTrastuzumab (EC-PPH) Indication • Neo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/EC-PPH-Cyclophosphamide-Epirubicin-Paclitaxel-Pertuzumab-Trastuzumab.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV-SC

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL- PERTUZUMABTRASTUZUMAB (IV/SC) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV/SC) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV-SC.pdf
401 to 410 of 1000
Previous … 39 40 41 42 43 … Next